Cargando…
Outcomes of blood and marrow transplantation in children less than 2-years of age: 23 years of experience at a single center
OBJECTIVES: Allogeneic hematopoietic cell transplantation (Allo-HCT) is a curative option for children with various malignant and non-malignant diseases. Most reports studied all age groups amongst children. Herein we analyzed our data in children transplanted at or less than 2-years of age. PATIENT...
Autores principales: | Khan, Saadiya, Siddiqui, Khawar, ElSolh, Hasan, AlJefri, Abdullah, AlAhmari, Ali, Ghemlas, Ibrahim, AlSaedi, Hawazen, AlEnazi, Awatif, AlSeraihi, Amal, Ayas, Mouhab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019952/ https://www.ncbi.nlm.nih.gov/pubmed/36937328 http://dx.doi.org/10.1016/j.ijpam.2022.09.002 |
Ejemplares similares
-
Can the bone marrow harvest volume be reduced safely in hematopoietic stem cell transplantation with pediatric sibling donors?
por: AlAnazi, Awatif, et al.
Publicado: (2023) -
Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience
por: Khan, Saadiya, et al.
Publicado: (2021) -
Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation?
por: Ramiz, Sarah, et al.
Publicado: (2023) -
Hematopoietic Stem Cell Transplantation Stabilizes Cerebral Vasculopathy in High-Risk Pediatric Sickle Cell Disease Patients: Evidence From a Referral Transplant Center
por: Al-Jefri, Abdullah, et al.
Publicado: (2022) -
Outcome of pediatric chronic myeloid leukemia with management focusing on the monitoring of BCR-ABL fusion gene transcript levels
por: Al-Ghemlas, Ibrahim, et al.
Publicado: (2022)